Isaac B. Meek

Isaac joined New England Biolabs in 2013, having previously held numerous marketing and commercial roles at Caliper Life Sciences (acquired by PerkinElmer), where he led the commercialization of Caliper’s genomics and next generation sequencing automation and microfluidics offering. As Director of Business Development, Isaac leads a team that is responsible for commercial partnerships, licensing, and new ventures. Isaac received his BS and MS from Texas A&M University, where he used sequencing and microarrays to study the molecular basis of secondary metabolism in microbes.